DrugFeb 22, 2023
Sentara Infusion Services CEFTRIAXONE (a) 1GM IN NS 50ML, (b)4GM IN NS 200ML, (c) 8GM IN NS recall — FDA D-0282-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
Latest records
Latest recalls — page 321
The newest recall records with useful source details are listed here.
DrugFeb 22, 2023
Sentara Infusion Services GANCICLOVIR ( CYTOVENE) (a)1480MG IN NS 296ML, (b) 740 MG IN NS recall — FDA D-0294-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Sentara Infusion Services Milrinone (a) 104MG IN 0.45% NS 130ML,(b) 108MG IN 0.45% NS 135ML recall — FDA D-0307-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Sentara Infusion Services Sodium Chloride 0.9 % (a) 100ML (MAGNESIUM) (b) 69.3ML, (c) recall — FDA D-0316-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Sentara Infusion Services Vancomycin (a) 1.25GM IN NS 250ML, (b) 1.5GM IN NS 300ML, (c) recall — FDA D-0322-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Sentara Infusion Services DAPTOMYCIN (a)360MG in NS 18ML syringe (b)580MG IN NS 29ML recall — FDA D-0286-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Sentara Infusion Services Lactated Ringers recall — FDA D-0300-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
HTO Nevada New & Improved Blue Gel Anesthetic, to reduce pain and swelling during pain recall — FDA D-0270-2023
cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.
Class IIFDA: TerminatedHTO Nevada, Inc.
DrugFeb 22, 2023
Sentara Infusion Services 0.9% Sodium Chloride, used as a diluent or hydration, packaged recall — FDA D-0272-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
McGuff Compounding Pharmacy Services Thiamine Hydrochloride 3000 mg/30 mL (100mg/mL) recall — FDA D-0267-2023
Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.
Class IIFDA: TerminatedMcGuff Compounding Pharmacy Services, Inc.
DrugFeb 22, 2023
Sentara Infusion Services PENICILLIN (a) 40MU IN D5W 400ML(CONTINUOUS), (b) 40U IN D5W recall — FDA D-0314-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Sentara Infusion Services PIPERACILLIN / TAZOBACTAM (a) 4.5GM IN NS 100 ML, (b)18GM IN NS recall — FDA D-0315-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Leadiant Biosciences Abelcet recall — FDA D-0327-2023
Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.
Class IIFDA: TerminatedLeadiant Biosciences, Inc.
DrugFeb 22, 2023
Sentara Infusion Services CEFAZOLIN (a) 12GM IN NS 600ML, (b) 2GM IN NS 100ML, (c) 2GM/20ML recall — FDA D-0278-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Sentara Infusion Services MEROPENEM (a) 1000MG IN NS 250ML, (b) 2GM IN NS 100ML, (c) 500mg recall — FDA D-0303-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
HTO Nevada Maximum Zone2 Topical Analgesic, 1oz bottle, for use during a pain sensitive recall — FDA D-0271-2023
cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.
Class IIFDA: TerminatedHTO Nevada, Inc.
DrugFeb 22, 2023
Sentara Infusion Services CEFEPIME, (a) 2GM IN NS 100ML (b)8GM IN NS 400ML (c) 12GM IN NS recall — FDA D-0280-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Sentara Infusion Services TPN 107gm/AA, 200gm/DEX, 50gm/LIP 2250mL, (b) 108GM/AA, 330GM/DEX recall — FDA D-0319-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
McGuff Compounding Pharmacy Services Thiamine Hydrochloride 200 mg/2mL (100mg/mL) recall — FDA D-0266-2023
Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.
Class IIFDA: TerminatedMcGuff Compounding Pharmacy Services, Inc.
DrugFeb 22, 2023
Sentara Infusion Services TPN (a) 100GM/AA, 285GM/DEX, (b)55GM/LIP 2300ML, (c)55GM/AA recall — FDA D-0318-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Sentara Infusion Services TPN (a) 95GM/AA, 385/DEX, 50GM/LIP 1800ML, (b)TPN AA:100GM recall — FDA D-0321-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
DrugFeb 22, 2023
Sentara Infusion Services HYDROMORPHONE (a) 1MG/ML IN NS, 50ML, 75 ML, 100ML, 175ML recall — FDA D-0296-2023
Lack of sterility assurance
Class IIFDA: TerminatedSentara Infusion Services
VehicleFeb 16, 2023
CR-V recliner recall — NHTSA campaign 23V092000
Honda (American Honda Motor Co.) is recalling certain 2023 CR-V vehicles. The front passenger seat back frame may not have been welded properly, which can cause the seat back position to…
reclinerHonda (American Honda Motor Co.)
VehicleFeb 16, 2023
Nissan key/sender recall — NHTSA campaign 23V093000
Nissan North America, Inc. (Nissan) is recalling certain 2014-2020 Rogue and 2017-2022 Rogue Sport vehicles equipped with a jackknife style ignition key. The jackknife key may collapse into…
key/senderNissan North America, Inc.
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025285 records · 4 categories